The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1075
Bid: 0.105
Ask: 0.11
Change: 0.00125 (1.18%)
Spread: 0.005 (4.762%)
Open: 0.10625
High: 0.00
Low: 0.00
Prev. Close: 0.10625
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

G-SCALE Update & Innovate UK Loan Variation

5 Dec 2022 07:00

RNS Number : 5199I
Versarien PLC
05 December 2022
 

 

 

 

5 December 2022

 

Versarien plc

("Versarien" or the "Company")

G-SCALE Update and Innovate UK Loan Deed of Variation

 

On 1 July 2020, Versarien plc (AIM: VRS), the advanced materials engineering group, announced that the UK Government, via Innovate UK ("IUK"), had agreed a £5 million loan to the Company (the "Loan"), for a project named G-SCALE, an acronym for Graphene, Seat, Concrete, Arch, Leisure, Elastomer. The award, which followed a rigorous process of assessment, was to facilitate the production of sufficient quantities of graphene to enable commercialisation of graphene-enhanced products in these five priority application areas.

 

IUK has continued to monitor the progress of the G-SCALE project during the drawdown and development stage, which has been completed despite the macro-economic challenges the Company has faced. In recognition of the potential benefits of Versarien's graphene technology, IUK offered to vary the terms of the Loan by deferring commencement of the capital repayments by one year, to be paid in ten equal quarterly repayments, commencing in August 2025. A deed of variation to the Loan has been signed by the Company accepting the offer. Interest will continue to be charged at a rate of 7.4% per annum, of which, 50% of the payments will be deferred until February 2025. The deferred interest will be paid in equal instalments when the capital repayments commence.

 

Versarien is pleased to provide a summary of G-SCALE progress under each of the headings:

 

"Graphene" - The Company has now commissioned the first of four "Graphene-Tech" reactors acquired as part of the project which in total could provide up to an additional 100 tonnes of powder capacity for use in multiple sectors including energy storage. The Graphink processing machines also purchased as part of the project are fully operational and can provide up to 12,000 kg of Cementene (Versarien's graphene enhanced concrete admixture) or 120,000 kg of Graphene-Wear formulation per annum.

 

"Seat" - Versarien has installed large scale dispersion systems to produce graphene-enhanced thermoset resins for incorporation into fibre-reinforced polymer composites. In parallel, the Company has completed its Technology Developer Accelerator Programme with Lotus Cars funded by the Advanced Propulsion Centre ("APC"). In addition, the Company has completed its Graphene-Loaded Polymer Composite project with the Defence, Science and Technology Laboratory ("DSTL") and continues talks with potential customers for graphene enhanced bio-resins as well as sustainable fibre reinforced thermoset polymers.

 

"Concrete" - Almost 1,000 tonnes of concrete have been poured containing Cementene. The Company is in discussions with major UK and European construction companies to assess product viability following the successful completion of testing by a United Kingdom Accredited Service ("UKAS") laboratory. Consequently, Versarien plans to continue investment in Graphink processing equipment to support its focus on the construction sector and the potential environmental benefits that can be obtained. The Company has also commissioned its 3d concrete printer and successfully completed several projects. Versarien intends to co-fund research fellowships as part of the Digital Roads of the Future project led by National Highways, housed at the University of Cambridge and the Company is a founding member of the Roads Research Alliance.

 

"Arch" - This application concentrates on commodity, speciality and engineering thermoplastics including adding graphene to recycled and bio-based feedstocks. Using graphene enhanced polymers manufactured by Versarien, Inspecs Group has produced prototype eyewear and is in the process of demonstrating these products to potential customers. The Company's academic collaborations with WMG at the University of Warwick continue and the first co-funded PhD student has now joined Versarien's Cambridge R&D team bringing additional expertise in graphene/thermoplastic processing.

 

"Leisure" - Versarien continues to progress its relationships with clothing brands Superdry, Umbro, BiaBrazil and Go To Gym. Some customer photoshoots have been completed for the Graphene-Wear product launches anticipated in Spring/Summer 2023, and designs have been completed for Autumn/Winter 2023 and Spring/Summer 2024. The Company is also in dialogue with other global sportswear brands with the aim to launch a number of new products.

 

"Elastomers" - Following the product launch with Flux Footwear LLC, the Company continues to take enquiries from global brands for Graphene-Wear rubber compounds and masterbatches. As part of this project, Versarien has completed a number of rounds of testing with Enso Tyres.

 

Neill Ricketts, Chief Executive Officer of Versarien, said: "The continuing support of various government agencies including Innovate UK, is an endorsement of the importance of graphene technology to the UK. Our core objective remains to leverage this exciting technology, especially in the construction and textile sectors, which we believe offer the fastest route to commercialisation."

 

Scott O'Brien, Director, Innovation Finance, Innovate UK & Director, Innovate UK Loans Limited, said: "We have continued to work with Versarien and to monitor this loan and the G-SCALE project it supports. Importantly, our loan was also predicated on the scale and breadth of commercial opportunities that could flow from G-SCALE. 

 

"We recognise the progress being made but we are also aware of the challenges we so often see for highly innovative businesses bringing ground-breaking technologies to market. In recognition of this and our continuing support for Versarien, we have offered additional flexibility around our loan: the planned start of capital repayments will be deferred for 12-months, extending the overall term of the loan. We hope this will assist in getting this ground-breaking material to market."

 

 For further information please contact:

 

Versarien Plc

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 887204

Chris Leigh - Chief Financial Officer

Stephen Hodge - Chief Technology Officer

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Adam Cowl

+44 (0) 20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0) 20 3207 7800

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien Plc

 

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

 

For further information please see: https://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIBDDRXGDGDS
Date   Source Headline
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.